Skip to main content

Table 3 Vaccine effectiveness (VE) of vaccination among different subgroups

From: The association between vaccine hesitancy and pertussis: a systematic review and meta-analysis

Vaccine Population

Variables

No. of studies

Estimated VE and 95% CI

\({I}^{2}\)

Pregnant Women

Study Outcome

   

Pertussis case

12 [7,8,9, 52,53,54,55,56,57,58,59,60]

89.83 (86.44, 93.35)

0%

Hospitalization

2 [9, 55]

80.60 (68.20, 95.26)

8%

Timing of vaccine administration

   

The third trimester

7 [8, 9, 52, 53, 57, 58, 60]

89.56 (85.66, 93.64)

0%

Any point during pregnancy

7 [7, 8, 53, 54, 56, 58, 59]

90.64 (83.99, 93.35)

0%

Children

Vaccine doses

   

1

3 [45, 48, 50]

66.25 (51.43, 85.35)

48%

2

3 [45, 48, 50]

80.12 (73.11, 87.80)

0%

3

2 [45, 46, 48]

89.71 (86.87, 92.65)

74%

4

1 [46]

95.00 (92.52, 97.55)

NA

5

1 [45]

89.00 (82.62, 95.88)

NA

All

4 [46, 47, 49, 50]

84.73 (78.41, 91.55)

0%

Study Outcome

   

Pertussis case

645–50

86.45 (83.45, 89.55)

71%

Hospitalization

148

92.04 (87.01, 97.36)

66%